1. Home
  2. BC vs RGEN Comparison

BC vs RGEN Comparison

Compare BC & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Brunswick Corporation

BC

Brunswick Corporation

HOLD

Current Price

$77.34

Market Cap

5.7B

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$103.52

Market Cap

6.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BC
RGEN
Founded
1845
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.7B
6.6B
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
BC
RGEN
Price
$77.34
$103.52
Analyst Decision
Buy
Buy
Analyst Count
11
12
Target Price
$83.55
$167.67
AVG Volume (30 Days)
656.8K
1.2M
Earning Date
04-30-2026
05-05-2026
Dividend Yield
2.22%
N/A
EPS Growth
N/A
286.96
EPS
N/A
0.15
Revenue
N/A
$141,236,000.00
Revenue This Year
$9.81
$14.30
Revenue Next Year
$5.11
$14.52
P/E Ratio
N/A
$689.70
Revenue Growth
N/A
35.10
52 Week Low
$48.83
$100.99
52 Week High
$90.25
$175.77

Technical Indicators

Market Signals
Indicator
BC
RGEN
Relative Strength Index (RSI) 47.41 32.43
Support Level $74.04 N/A
Resistance Level $84.25 $129.77
Average True Range (ATR) 2.95 5.90
MACD -0.34 -2.01
Stochastic Oscillator 36.78 7.09

Price Performance

Historical Comparison
BC
RGEN

About BC Brunswick Corporation

Brunswick is a leading manufacturer in the marine recreation industry. The firm has more than 60 brands delivering products across propulsion (outboard, sterndrive, and inboard engines, propulsion-related controls, rigging, and propellers), parts, accessories, and technology, and boats (including well-known brands like Boston Whaler and Sea Ray). It also owns 442 Freedom Boat Club locations as well as Boateka, which facilitates transactions in the used-boat market. Brunswick's focus surrounds building the innovative marine and recreational experiences, technologies, and connections supported by quality and innovation.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia Pacific contribute about 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: